Global and China Prostate Biopsy System

Prostate Biopsy System Comprehensive Study by Type (3D Imaging, Navigation System), Application (Hospitals, Ambulatory Surgical Center (ASCs), Diagnostic Centers, Others), Prostate (Benign Prostatic Hyperplasia, Prostatic Adenocarcinoma, Small Cell Carcinoma, Others) Players and Region - Global Market Outlook to 2027

Prostate Biopsy System Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
The prostate Biopsy system is designed to provide high quality and reliable core samples. It is the system provides consistent, excellent core samples. With the help of a prostate biopsy needle which collects the number of tissue samples from the prostate gland. This procedure is performed by skilled professionals who specialize in the urinary system and men's sex organs. It makes easy access to the tissue sample. This system helps in achieving high detection rates increase in diagnostic certainty in the case of carcinoma.This growth is primarily driven by Increase in Incidence Rate of Prostate Cancer Majorly In the United States and Europe Region, Rise in Awareness about Disease among People and Growing Number of Geriatric Male Population across the Globe.

Globally, a noticeable market trend is evident Increasing Demand for Reusable Prostate Biopsy Systems. Major Players, such as Bard (Georgia), Argon Medical Devices (United States), Philips (Netherlands), Cook Group (United States), UROMED (United States), Sterylab (Italy), Boston Scientific Corporation (United States), Geotekmedical (Turkey), Eigen (United States) and Samsung Healthcare (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Market Drivers
  • Increase in Incidence Rate of Prostate Cancer Majorly In the United States and Europe Region
  • Rise in Awareness about Disease among People
  • Growing Number of Geriatric Male Population across the Globe

Market Trend
  • Increasing Demand for Reusable Prostate Biopsy Systems

Restraints
  • Lack of Availability of Advanced Biopsy Procedures and Treatment in Few Regions Includes Iran, Lebanon, and Others

Opportunities
Development in Healthcare Infrastructure in Asia Pacific Regions for Prostate Cancer
Challenges
High Cost Associated With Biopsy Procedures and Shortage of Skilled Professionals

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Prostate Biopsy System Study Sheds Light on
— The Prostate Biopsy System Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Prostate Biopsy System industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Prostate Biopsy System industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • 3D Imaging
  • Navigation System
By Application
  • Hospitals
  • Ambulatory Surgical Center (ASCs)
  • Diagnostic Centers
  • Others
By Prostate
  • Benign Prostatic Hyperplasia
  • Prostatic Adenocarcinoma
  • Small Cell Carcinoma
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in Incidence Rate of Prostate Cancer Majorly In the United States and Europe Region
      • 3.2.2. Rise in Awareness about Disease among People
      • 3.2.3. Growing Number of Geriatric Male Population across the Globe
    • 3.3. Market Challenges
      • 3.3.1. High Cost Associated With Biopsy Procedures and Shortage of Skilled Professionals
    • 3.4. Market Trends
      • 3.4.1. Increasing Demand for Reusable Prostate Biopsy Systems
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Prostate Biopsy System, by Type, Application, Prostate and Region (value, volume and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Prostate Biopsy System (Value)
      • 5.2.1. Global Prostate Biopsy System by: Type (Value)
        • 5.2.1.1. 3D Imaging
        • 5.2.1.2. Navigation System
      • 5.2.2. Global Prostate Biopsy System by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Ambulatory Surgical Center (ASCs)
        • 5.2.2.3. Diagnostic Centers
        • 5.2.2.4. Others
      • 5.2.3. Global Prostate Biopsy System by: Prostate (Value)
        • 5.2.3.1. Benign Prostatic Hyperplasia
        • 5.2.3.2. Prostatic Adenocarcinoma
        • 5.2.3.3. Small Cell Carcinoma
        • 5.2.3.4. Others
      • 5.2.4. Global Prostate Biopsy System Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Prostate Biopsy System (Volume)
      • 5.3.1. Global Prostate Biopsy System by: Type (Volume)
        • 5.3.1.1. 3D Imaging
        • 5.3.1.2. Navigation System
      • 5.3.2. Global Prostate Biopsy System by: Application (Volume)
        • 5.3.2.1. Hospitals
        • 5.3.2.2. Ambulatory Surgical Center (ASCs)
        • 5.3.2.3. Diagnostic Centers
        • 5.3.2.4. Others
      • 5.3.3. Global Prostate Biopsy System by: Prostate (Volume)
        • 5.3.3.1. Benign Prostatic Hyperplasia
        • 5.3.3.2. Prostatic Adenocarcinoma
        • 5.3.3.3. Small Cell Carcinoma
        • 5.3.3.4. Others
      • 5.3.4. Global Prostate Biopsy System Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Prostate Biopsy System (Price)
      • 5.4.1. Global Prostate Biopsy System by: Type (Price)
  • 6. Prostate Biopsy System: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Bard (Georgia)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Argon Medical Devices (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Philips (Netherlands)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Cook Group (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. UROMED (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Sterylab (Italy)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Boston Scientific Corporation (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Geotekmedical (Turkey)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Eigen (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Samsung Healthcare (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Prostate Biopsy System Sale, by Type, Application, Prostate and Region (value, volume and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Prostate Biopsy System (Value)
      • 7.2.1. Global Prostate Biopsy System by: Type (Value)
        • 7.2.1.1. 3D Imaging
        • 7.2.1.2. Navigation System
      • 7.2.2. Global Prostate Biopsy System by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Ambulatory Surgical Center (ASCs)
        • 7.2.2.3. Diagnostic Centers
        • 7.2.2.4. Others
      • 7.2.3. Global Prostate Biopsy System by: Prostate (Value)
        • 7.2.3.1. Benign Prostatic Hyperplasia
        • 7.2.3.2. Prostatic Adenocarcinoma
        • 7.2.3.3. Small Cell Carcinoma
        • 7.2.3.4. Others
      • 7.2.4. Global Prostate Biopsy System Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Prostate Biopsy System (Volume)
      • 7.3.1. Global Prostate Biopsy System by: Type (Volume)
        • 7.3.1.1. 3D Imaging
        • 7.3.1.2. Navigation System
      • 7.3.2. Global Prostate Biopsy System by: Application (Volume)
        • 7.3.2.1. Hospitals
        • 7.3.2.2. Ambulatory Surgical Center (ASCs)
        • 7.3.2.3. Diagnostic Centers
        • 7.3.2.4. Others
      • 7.3.3. Global Prostate Biopsy System by: Prostate (Volume)
        • 7.3.3.1. Benign Prostatic Hyperplasia
        • 7.3.3.2. Prostatic Adenocarcinoma
        • 7.3.3.3. Small Cell Carcinoma
        • 7.3.3.4. Others
      • 7.3.4. Global Prostate Biopsy System Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Prostate Biopsy System (Price)
      • 7.4.1. Global Prostate Biopsy System by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Prostate Biopsy System: by Type(USD Million)
  • Table 2. Prostate Biopsy System 3D Imaging , by Region USD Million (2016-2021)
  • Table 3. Prostate Biopsy System Navigation System , by Region USD Million (2016-2021)
  • Table 4. Prostate Biopsy System: by Application(USD Million)
  • Table 5. Prostate Biopsy System Hospitals , by Region USD Million (2016-2021)
  • Table 6. Prostate Biopsy System Ambulatory Surgical Center (ASCs) , by Region USD Million (2016-2021)
  • Table 7. Prostate Biopsy System Diagnostic Centers , by Region USD Million (2016-2021)
  • Table 8. Prostate Biopsy System Others , by Region USD Million (2016-2021)
  • Table 9. Prostate Biopsy System: by Prostate(USD Million)
  • Table 10. Prostate Biopsy System Benign Prostatic Hyperplasia , by Region USD Million (2016-2021)
  • Table 11. Prostate Biopsy System Prostatic Adenocarcinoma , by Region USD Million (2016-2021)
  • Table 12. Prostate Biopsy System Small Cell Carcinoma , by Region USD Million (2016-2021)
  • Table 13. Prostate Biopsy System Others , by Region USD Million (2016-2021)
  • Table 14. South America Prostate Biopsy System, by Country USD Million (2016-2021)
  • Table 15. South America Prostate Biopsy System, by Type USD Million (2016-2021)
  • Table 16. South America Prostate Biopsy System, by Application USD Million (2016-2021)
  • Table 17. South America Prostate Biopsy System, by Prostate USD Million (2016-2021)
  • Table 18. Brazil Prostate Biopsy System, by Type USD Million (2016-2021)
  • Table 19. Brazil Prostate Biopsy System, by Application USD Million (2016-2021)
  • Table 20. Brazil Prostate Biopsy System, by Prostate USD Million (2016-2021)
  • Table 21. Argentina Prostate Biopsy System, by Type USD Million (2016-2021)
  • Table 22. Argentina Prostate Biopsy System, by Application USD Million (2016-2021)
  • Table 23. Argentina Prostate Biopsy System, by Prostate USD Million (2016-2021)
  • Table 24. Rest of South America Prostate Biopsy System, by Type USD Million (2016-2021)
  • Table 25. Rest of South America Prostate Biopsy System, by Application USD Million (2016-2021)
  • Table 26. Rest of South America Prostate Biopsy System, by Prostate USD Million (2016-2021)
  • Table 27. Asia Pacific Prostate Biopsy System, by Country USD Million (2016-2021)
  • Table 28. Asia Pacific Prostate Biopsy System, by Type USD Million (2016-2021)
  • Table 29. Asia Pacific Prostate Biopsy System, by Application USD Million (2016-2021)
  • Table 30. Asia Pacific Prostate Biopsy System, by Prostate USD Million (2016-2021)
  • Table 31. China Prostate Biopsy System, by Type USD Million (2016-2021)
  • Table 32. China Prostate Biopsy System, by Application USD Million (2016-2021)
  • Table 33. China Prostate Biopsy System, by Prostate USD Million (2016-2021)
  • Table 34. Japan Prostate Biopsy System, by Type USD Million (2016-2021)
  • Table 35. Japan Prostate Biopsy System, by Application USD Million (2016-2021)
  • Table 36. Japan Prostate Biopsy System, by Prostate USD Million (2016-2021)
  • Table 37. India Prostate Biopsy System, by Type USD Million (2016-2021)
  • Table 38. India Prostate Biopsy System, by Application USD Million (2016-2021)
  • Table 39. India Prostate Biopsy System, by Prostate USD Million (2016-2021)
  • Table 40. South Korea Prostate Biopsy System, by Type USD Million (2016-2021)
  • Table 41. South Korea Prostate Biopsy System, by Application USD Million (2016-2021)
  • Table 42. South Korea Prostate Biopsy System, by Prostate USD Million (2016-2021)
  • Table 43. Taiwan Prostate Biopsy System, by Type USD Million (2016-2021)
  • Table 44. Taiwan Prostate Biopsy System, by Application USD Million (2016-2021)
  • Table 45. Taiwan Prostate Biopsy System, by Prostate USD Million (2016-2021)
  • Table 46. Australia Prostate Biopsy System, by Type USD Million (2016-2021)
  • Table 47. Australia Prostate Biopsy System, by Application USD Million (2016-2021)
  • Table 48. Australia Prostate Biopsy System, by Prostate USD Million (2016-2021)
  • Table 49. Rest of Asia-Pacific Prostate Biopsy System, by Type USD Million (2016-2021)
  • Table 50. Rest of Asia-Pacific Prostate Biopsy System, by Application USD Million (2016-2021)
  • Table 51. Rest of Asia-Pacific Prostate Biopsy System, by Prostate USD Million (2016-2021)
  • Table 52. Europe Prostate Biopsy System, by Country USD Million (2016-2021)
  • Table 53. Europe Prostate Biopsy System, by Type USD Million (2016-2021)
  • Table 54. Europe Prostate Biopsy System, by Application USD Million (2016-2021)
  • Table 55. Europe Prostate Biopsy System, by Prostate USD Million (2016-2021)
  • Table 56. Germany Prostate Biopsy System, by Type USD Million (2016-2021)
  • Table 57. Germany Prostate Biopsy System, by Application USD Million (2016-2021)
  • Table 58. Germany Prostate Biopsy System, by Prostate USD Million (2016-2021)
  • Table 59. France Prostate Biopsy System, by Type USD Million (2016-2021)
  • Table 60. France Prostate Biopsy System, by Application USD Million (2016-2021)
  • Table 61. France Prostate Biopsy System, by Prostate USD Million (2016-2021)
  • Table 62. Italy Prostate Biopsy System, by Type USD Million (2016-2021)
  • Table 63. Italy Prostate Biopsy System, by Application USD Million (2016-2021)
  • Table 64. Italy Prostate Biopsy System, by Prostate USD Million (2016-2021)
  • Table 65. United Kingdom Prostate Biopsy System, by Type USD Million (2016-2021)
  • Table 66. United Kingdom Prostate Biopsy System, by Application USD Million (2016-2021)
  • Table 67. United Kingdom Prostate Biopsy System, by Prostate USD Million (2016-2021)
  • Table 68. Netherlands Prostate Biopsy System, by Type USD Million (2016-2021)
  • Table 69. Netherlands Prostate Biopsy System, by Application USD Million (2016-2021)
  • Table 70. Netherlands Prostate Biopsy System, by Prostate USD Million (2016-2021)
  • Table 71. Rest of Europe Prostate Biopsy System, by Type USD Million (2016-2021)
  • Table 72. Rest of Europe Prostate Biopsy System, by Application USD Million (2016-2021)
  • Table 73. Rest of Europe Prostate Biopsy System, by Prostate USD Million (2016-2021)
  • Table 74. MEA Prostate Biopsy System, by Country USD Million (2016-2021)
  • Table 75. MEA Prostate Biopsy System, by Type USD Million (2016-2021)
  • Table 76. MEA Prostate Biopsy System, by Application USD Million (2016-2021)
  • Table 77. MEA Prostate Biopsy System, by Prostate USD Million (2016-2021)
  • Table 78. Middle East Prostate Biopsy System, by Type USD Million (2016-2021)
  • Table 79. Middle East Prostate Biopsy System, by Application USD Million (2016-2021)
  • Table 80. Middle East Prostate Biopsy System, by Prostate USD Million (2016-2021)
  • Table 81. Africa Prostate Biopsy System, by Type USD Million (2016-2021)
  • Table 82. Africa Prostate Biopsy System, by Application USD Million (2016-2021)
  • Table 83. Africa Prostate Biopsy System, by Prostate USD Million (2016-2021)
  • Table 84. North America Prostate Biopsy System, by Country USD Million (2016-2021)
  • Table 85. North America Prostate Biopsy System, by Type USD Million (2016-2021)
  • Table 86. North America Prostate Biopsy System, by Application USD Million (2016-2021)
  • Table 87. North America Prostate Biopsy System, by Prostate USD Million (2016-2021)
  • Table 88. United States Prostate Biopsy System, by Type USD Million (2016-2021)
  • Table 89. United States Prostate Biopsy System, by Application USD Million (2016-2021)
  • Table 90. United States Prostate Biopsy System, by Prostate USD Million (2016-2021)
  • Table 91. Canada Prostate Biopsy System, by Type USD Million (2016-2021)
  • Table 92. Canada Prostate Biopsy System, by Application USD Million (2016-2021)
  • Table 93. Canada Prostate Biopsy System, by Prostate USD Million (2016-2021)
  • Table 94. Mexico Prostate Biopsy System, by Type USD Million (2016-2021)
  • Table 95. Mexico Prostate Biopsy System, by Application USD Million (2016-2021)
  • Table 96. Mexico Prostate Biopsy System, by Prostate USD Million (2016-2021)
  • Table 97. Prostate Biopsy System Sales: by Type(K Units)
  • Table 98. Prostate Biopsy System Sales 3D Imaging , by Region K Units (2016-2021)
  • Table 99. Prostate Biopsy System Sales Navigation System , by Region K Units (2016-2021)
  • Table 100. Prostate Biopsy System Sales: by Application(K Units)
  • Table 101. Prostate Biopsy System Sales Hospitals , by Region K Units (2016-2021)
  • Table 102. Prostate Biopsy System Sales Ambulatory Surgical Center (ASCs) , by Region K Units (2016-2021)
  • Table 103. Prostate Biopsy System Sales Diagnostic Centers , by Region K Units (2016-2021)
  • Table 104. Prostate Biopsy System Sales Others , by Region K Units (2016-2021)
  • Table 105. Prostate Biopsy System Sales: by Prostate(K Units)
  • Table 106. Prostate Biopsy System Sales Benign Prostatic Hyperplasia , by Region K Units (2016-2021)
  • Table 107. Prostate Biopsy System Sales Prostatic Adenocarcinoma , by Region K Units (2016-2021)
  • Table 108. Prostate Biopsy System Sales Small Cell Carcinoma , by Region K Units (2016-2021)
  • Table 109. Prostate Biopsy System Sales Others , by Region K Units (2016-2021)
  • Table 110. South America Prostate Biopsy System Sales, by Country K Units (2016-2021)
  • Table 111. South America Prostate Biopsy System Sales, by Type K Units (2016-2021)
  • Table 112. South America Prostate Biopsy System Sales, by Application K Units (2016-2021)
  • Table 113. South America Prostate Biopsy System Sales, by Prostate K Units (2016-2021)
  • Table 114. Brazil Prostate Biopsy System Sales, by Type K Units (2016-2021)
  • Table 115. Brazil Prostate Biopsy System Sales, by Application K Units (2016-2021)
  • Table 116. Brazil Prostate Biopsy System Sales, by Prostate K Units (2016-2021)
  • Table 117. Argentina Prostate Biopsy System Sales, by Type K Units (2016-2021)
  • Table 118. Argentina Prostate Biopsy System Sales, by Application K Units (2016-2021)
  • Table 119. Argentina Prostate Biopsy System Sales, by Prostate K Units (2016-2021)
  • Table 120. Rest of South America Prostate Biopsy System Sales, by Type K Units (2016-2021)
  • Table 121. Rest of South America Prostate Biopsy System Sales, by Application K Units (2016-2021)
  • Table 122. Rest of South America Prostate Biopsy System Sales, by Prostate K Units (2016-2021)
  • Table 123. Asia Pacific Prostate Biopsy System Sales, by Country K Units (2016-2021)
  • Table 124. Asia Pacific Prostate Biopsy System Sales, by Type K Units (2016-2021)
  • Table 125. Asia Pacific Prostate Biopsy System Sales, by Application K Units (2016-2021)
  • Table 126. Asia Pacific Prostate Biopsy System Sales, by Prostate K Units (2016-2021)
  • Table 127. China Prostate Biopsy System Sales, by Type K Units (2016-2021)
  • Table 128. China Prostate Biopsy System Sales, by Application K Units (2016-2021)
  • Table 129. China Prostate Biopsy System Sales, by Prostate K Units (2016-2021)
  • Table 130. Japan Prostate Biopsy System Sales, by Type K Units (2016-2021)
  • Table 131. Japan Prostate Biopsy System Sales, by Application K Units (2016-2021)
  • Table 132. Japan Prostate Biopsy System Sales, by Prostate K Units (2016-2021)
  • Table 133. India Prostate Biopsy System Sales, by Type K Units (2016-2021)
  • Table 134. India Prostate Biopsy System Sales, by Application K Units (2016-2021)
  • Table 135. India Prostate Biopsy System Sales, by Prostate K Units (2016-2021)
  • Table 136. South Korea Prostate Biopsy System Sales, by Type K Units (2016-2021)
  • Table 137. South Korea Prostate Biopsy System Sales, by Application K Units (2016-2021)
  • Table 138. South Korea Prostate Biopsy System Sales, by Prostate K Units (2016-2021)
  • Table 139. Taiwan Prostate Biopsy System Sales, by Type K Units (2016-2021)
  • Table 140. Taiwan Prostate Biopsy System Sales, by Application K Units (2016-2021)
  • Table 141. Taiwan Prostate Biopsy System Sales, by Prostate K Units (2016-2021)
  • Table 142. Australia Prostate Biopsy System Sales, by Type K Units (2016-2021)
  • Table 143. Australia Prostate Biopsy System Sales, by Application K Units (2016-2021)
  • Table 144. Australia Prostate Biopsy System Sales, by Prostate K Units (2016-2021)
  • Table 145. Rest of Asia-Pacific Prostate Biopsy System Sales, by Type K Units (2016-2021)
  • Table 146. Rest of Asia-Pacific Prostate Biopsy System Sales, by Application K Units (2016-2021)
  • Table 147. Rest of Asia-Pacific Prostate Biopsy System Sales, by Prostate K Units (2016-2021)
  • Table 148. Europe Prostate Biopsy System Sales, by Country K Units (2016-2021)
  • Table 149. Europe Prostate Biopsy System Sales, by Type K Units (2016-2021)
  • Table 150. Europe Prostate Biopsy System Sales, by Application K Units (2016-2021)
  • Table 151. Europe Prostate Biopsy System Sales, by Prostate K Units (2016-2021)
  • Table 152. Germany Prostate Biopsy System Sales, by Type K Units (2016-2021)
  • Table 153. Germany Prostate Biopsy System Sales, by Application K Units (2016-2021)
  • Table 154. Germany Prostate Biopsy System Sales, by Prostate K Units (2016-2021)
  • Table 155. France Prostate Biopsy System Sales, by Type K Units (2016-2021)
  • Table 156. France Prostate Biopsy System Sales, by Application K Units (2016-2021)
  • Table 157. France Prostate Biopsy System Sales, by Prostate K Units (2016-2021)
  • Table 158. Italy Prostate Biopsy System Sales, by Type K Units (2016-2021)
  • Table 159. Italy Prostate Biopsy System Sales, by Application K Units (2016-2021)
  • Table 160. Italy Prostate Biopsy System Sales, by Prostate K Units (2016-2021)
  • Table 161. United Kingdom Prostate Biopsy System Sales, by Type K Units (2016-2021)
  • Table 162. United Kingdom Prostate Biopsy System Sales, by Application K Units (2016-2021)
  • Table 163. United Kingdom Prostate Biopsy System Sales, by Prostate K Units (2016-2021)
  • Table 164. Netherlands Prostate Biopsy System Sales, by Type K Units (2016-2021)
  • Table 165. Netherlands Prostate Biopsy System Sales, by Application K Units (2016-2021)
  • Table 166. Netherlands Prostate Biopsy System Sales, by Prostate K Units (2016-2021)
  • Table 167. Rest of Europe Prostate Biopsy System Sales, by Type K Units (2016-2021)
  • Table 168. Rest of Europe Prostate Biopsy System Sales, by Application K Units (2016-2021)
  • Table 169. Rest of Europe Prostate Biopsy System Sales, by Prostate K Units (2016-2021)
  • Table 170. MEA Prostate Biopsy System Sales, by Country K Units (2016-2021)
  • Table 171. MEA Prostate Biopsy System Sales, by Type K Units (2016-2021)
  • Table 172. MEA Prostate Biopsy System Sales, by Application K Units (2016-2021)
  • Table 173. MEA Prostate Biopsy System Sales, by Prostate K Units (2016-2021)
  • Table 174. Middle East Prostate Biopsy System Sales, by Type K Units (2016-2021)
  • Table 175. Middle East Prostate Biopsy System Sales, by Application K Units (2016-2021)
  • Table 176. Middle East Prostate Biopsy System Sales, by Prostate K Units (2016-2021)
  • Table 177. Africa Prostate Biopsy System Sales, by Type K Units (2016-2021)
  • Table 178. Africa Prostate Biopsy System Sales, by Application K Units (2016-2021)
  • Table 179. Africa Prostate Biopsy System Sales, by Prostate K Units (2016-2021)
  • Table 180. North America Prostate Biopsy System Sales, by Country K Units (2016-2021)
  • Table 181. North America Prostate Biopsy System Sales, by Type K Units (2016-2021)
  • Table 182. North America Prostate Biopsy System Sales, by Application K Units (2016-2021)
  • Table 183. North America Prostate Biopsy System Sales, by Prostate K Units (2016-2021)
  • Table 184. United States Prostate Biopsy System Sales, by Type K Units (2016-2021)
  • Table 185. United States Prostate Biopsy System Sales, by Application K Units (2016-2021)
  • Table 186. United States Prostate Biopsy System Sales, by Prostate K Units (2016-2021)
  • Table 187. Canada Prostate Biopsy System Sales, by Type K Units (2016-2021)
  • Table 188. Canada Prostate Biopsy System Sales, by Application K Units (2016-2021)
  • Table 189. Canada Prostate Biopsy System Sales, by Prostate K Units (2016-2021)
  • Table 190. Mexico Prostate Biopsy System Sales, by Type K Units (2016-2021)
  • Table 191. Mexico Prostate Biopsy System Sales, by Application K Units (2016-2021)
  • Table 192. Mexico Prostate Biopsy System Sales, by Prostate K Units (2016-2021)
  • Table 193. Prostate Biopsy System: by Type(USD/Units)
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Company Basic Information, Sales Area and Its Competitors
  • Table 204. Prostate Biopsy System: by Type(USD Million)
  • Table 205. Prostate Biopsy System 3D Imaging , by Region USD Million (2022-2027)
  • Table 206. Prostate Biopsy System Navigation System , by Region USD Million (2022-2027)
  • Table 207. Prostate Biopsy System: by Application(USD Million)
  • Table 208. Prostate Biopsy System Hospitals , by Region USD Million (2022-2027)
  • Table 209. Prostate Biopsy System Ambulatory Surgical Center (ASCs) , by Region USD Million (2022-2027)
  • Table 210. Prostate Biopsy System Diagnostic Centers , by Region USD Million (2022-2027)
  • Table 211. Prostate Biopsy System Others , by Region USD Million (2022-2027)
  • Table 212. Prostate Biopsy System: by Prostate(USD Million)
  • Table 213. Prostate Biopsy System Benign Prostatic Hyperplasia , by Region USD Million (2022-2027)
  • Table 214. Prostate Biopsy System Prostatic Adenocarcinoma , by Region USD Million (2022-2027)
  • Table 215. Prostate Biopsy System Small Cell Carcinoma , by Region USD Million (2022-2027)
  • Table 216. Prostate Biopsy System Others , by Region USD Million (2022-2027)
  • Table 217. South America Prostate Biopsy System, by Country USD Million (2022-2027)
  • Table 218. South America Prostate Biopsy System, by Type USD Million (2022-2027)
  • Table 219. South America Prostate Biopsy System, by Application USD Million (2022-2027)
  • Table 220. South America Prostate Biopsy System, by Prostate USD Million (2022-2027)
  • Table 221. Brazil Prostate Biopsy System, by Type USD Million (2022-2027)
  • Table 222. Brazil Prostate Biopsy System, by Application USD Million (2022-2027)
  • Table 223. Brazil Prostate Biopsy System, by Prostate USD Million (2022-2027)
  • Table 224. Argentina Prostate Biopsy System, by Type USD Million (2022-2027)
  • Table 225. Argentina Prostate Biopsy System, by Application USD Million (2022-2027)
  • Table 226. Argentina Prostate Biopsy System, by Prostate USD Million (2022-2027)
  • Table 227. Rest of South America Prostate Biopsy System, by Type USD Million (2022-2027)
  • Table 228. Rest of South America Prostate Biopsy System, by Application USD Million (2022-2027)
  • Table 229. Rest of South America Prostate Biopsy System, by Prostate USD Million (2022-2027)
  • Table 230. Asia Pacific Prostate Biopsy System, by Country USD Million (2022-2027)
  • Table 231. Asia Pacific Prostate Biopsy System, by Type USD Million (2022-2027)
  • Table 232. Asia Pacific Prostate Biopsy System, by Application USD Million (2022-2027)
  • Table 233. Asia Pacific Prostate Biopsy System, by Prostate USD Million (2022-2027)
  • Table 234. China Prostate Biopsy System, by Type USD Million (2022-2027)
  • Table 235. China Prostate Biopsy System, by Application USD Million (2022-2027)
  • Table 236. China Prostate Biopsy System, by Prostate USD Million (2022-2027)
  • Table 237. Japan Prostate Biopsy System, by Type USD Million (2022-2027)
  • Table 238. Japan Prostate Biopsy System, by Application USD Million (2022-2027)
  • Table 239. Japan Prostate Biopsy System, by Prostate USD Million (2022-2027)
  • Table 240. India Prostate Biopsy System, by Type USD Million (2022-2027)
  • Table 241. India Prostate Biopsy System, by Application USD Million (2022-2027)
  • Table 242. India Prostate Biopsy System, by Prostate USD Million (2022-2027)
  • Table 243. South Korea Prostate Biopsy System, by Type USD Million (2022-2027)
  • Table 244. South Korea Prostate Biopsy System, by Application USD Million (2022-2027)
  • Table 245. South Korea Prostate Biopsy System, by Prostate USD Million (2022-2027)
  • Table 246. Taiwan Prostate Biopsy System, by Type USD Million (2022-2027)
  • Table 247. Taiwan Prostate Biopsy System, by Application USD Million (2022-2027)
  • Table 248. Taiwan Prostate Biopsy System, by Prostate USD Million (2022-2027)
  • Table 249. Australia Prostate Biopsy System, by Type USD Million (2022-2027)
  • Table 250. Australia Prostate Biopsy System, by Application USD Million (2022-2027)
  • Table 251. Australia Prostate Biopsy System, by Prostate USD Million (2022-2027)
  • Table 252. Rest of Asia-Pacific Prostate Biopsy System, by Type USD Million (2022-2027)
  • Table 253. Rest of Asia-Pacific Prostate Biopsy System, by Application USD Million (2022-2027)
  • Table 254. Rest of Asia-Pacific Prostate Biopsy System, by Prostate USD Million (2022-2027)
  • Table 255. Europe Prostate Biopsy System, by Country USD Million (2022-2027)
  • Table 256. Europe Prostate Biopsy System, by Type USD Million (2022-2027)
  • Table 257. Europe Prostate Biopsy System, by Application USD Million (2022-2027)
  • Table 258. Europe Prostate Biopsy System, by Prostate USD Million (2022-2027)
  • Table 259. Germany Prostate Biopsy System, by Type USD Million (2022-2027)
  • Table 260. Germany Prostate Biopsy System, by Application USD Million (2022-2027)
  • Table 261. Germany Prostate Biopsy System, by Prostate USD Million (2022-2027)
  • Table 262. France Prostate Biopsy System, by Type USD Million (2022-2027)
  • Table 263. France Prostate Biopsy System, by Application USD Million (2022-2027)
  • Table 264. France Prostate Biopsy System, by Prostate USD Million (2022-2027)
  • Table 265. Italy Prostate Biopsy System, by Type USD Million (2022-2027)
  • Table 266. Italy Prostate Biopsy System, by Application USD Million (2022-2027)
  • Table 267. Italy Prostate Biopsy System, by Prostate USD Million (2022-2027)
  • Table 268. United Kingdom Prostate Biopsy System, by Type USD Million (2022-2027)
  • Table 269. United Kingdom Prostate Biopsy System, by Application USD Million (2022-2027)
  • Table 270. United Kingdom Prostate Biopsy System, by Prostate USD Million (2022-2027)
  • Table 271. Netherlands Prostate Biopsy System, by Type USD Million (2022-2027)
  • Table 272. Netherlands Prostate Biopsy System, by Application USD Million (2022-2027)
  • Table 273. Netherlands Prostate Biopsy System, by Prostate USD Million (2022-2027)
  • Table 274. Rest of Europe Prostate Biopsy System, by Type USD Million (2022-2027)
  • Table 275. Rest of Europe Prostate Biopsy System, by Application USD Million (2022-2027)
  • Table 276. Rest of Europe Prostate Biopsy System, by Prostate USD Million (2022-2027)
  • Table 277. MEA Prostate Biopsy System, by Country USD Million (2022-2027)
  • Table 278. MEA Prostate Biopsy System, by Type USD Million (2022-2027)
  • Table 279. MEA Prostate Biopsy System, by Application USD Million (2022-2027)
  • Table 280. MEA Prostate Biopsy System, by Prostate USD Million (2022-2027)
  • Table 281. Middle East Prostate Biopsy System, by Type USD Million (2022-2027)
  • Table 282. Middle East Prostate Biopsy System, by Application USD Million (2022-2027)
  • Table 283. Middle East Prostate Biopsy System, by Prostate USD Million (2022-2027)
  • Table 284. Africa Prostate Biopsy System, by Type USD Million (2022-2027)
  • Table 285. Africa Prostate Biopsy System, by Application USD Million (2022-2027)
  • Table 286. Africa Prostate Biopsy System, by Prostate USD Million (2022-2027)
  • Table 287. North America Prostate Biopsy System, by Country USD Million (2022-2027)
  • Table 288. North America Prostate Biopsy System, by Type USD Million (2022-2027)
  • Table 289. North America Prostate Biopsy System, by Application USD Million (2022-2027)
  • Table 290. North America Prostate Biopsy System, by Prostate USD Million (2022-2027)
  • Table 291. United States Prostate Biopsy System, by Type USD Million (2022-2027)
  • Table 292. United States Prostate Biopsy System, by Application USD Million (2022-2027)
  • Table 293. United States Prostate Biopsy System, by Prostate USD Million (2022-2027)
  • Table 294. Canada Prostate Biopsy System, by Type USD Million (2022-2027)
  • Table 295. Canada Prostate Biopsy System, by Application USD Million (2022-2027)
  • Table 296. Canada Prostate Biopsy System, by Prostate USD Million (2022-2027)
  • Table 297. Mexico Prostate Biopsy System, by Type USD Million (2022-2027)
  • Table 298. Mexico Prostate Biopsy System, by Application USD Million (2022-2027)
  • Table 299. Mexico Prostate Biopsy System, by Prostate USD Million (2022-2027)
  • Table 300. Prostate Biopsy System Sales: by Type(K Units)
  • Table 301. Prostate Biopsy System Sales 3D Imaging , by Region K Units (2022-2027)
  • Table 302. Prostate Biopsy System Sales Navigation System , by Region K Units (2022-2027)
  • Table 303. Prostate Biopsy System Sales: by Application(K Units)
  • Table 304. Prostate Biopsy System Sales Hospitals , by Region K Units (2022-2027)
  • Table 305. Prostate Biopsy System Sales Ambulatory Surgical Center (ASCs) , by Region K Units (2022-2027)
  • Table 306. Prostate Biopsy System Sales Diagnostic Centers , by Region K Units (2022-2027)
  • Table 307. Prostate Biopsy System Sales Others , by Region K Units (2022-2027)
  • Table 308. Prostate Biopsy System Sales: by Prostate(K Units)
  • Table 309. Prostate Biopsy System Sales Benign Prostatic Hyperplasia , by Region K Units (2022-2027)
  • Table 310. Prostate Biopsy System Sales Prostatic Adenocarcinoma , by Region K Units (2022-2027)
  • Table 311. Prostate Biopsy System Sales Small Cell Carcinoma , by Region K Units (2022-2027)
  • Table 312. Prostate Biopsy System Sales Others , by Region K Units (2022-2027)
  • Table 313. South America Prostate Biopsy System Sales, by Country K Units (2022-2027)
  • Table 314. South America Prostate Biopsy System Sales, by Type K Units (2022-2027)
  • Table 315. South America Prostate Biopsy System Sales, by Application K Units (2022-2027)
  • Table 316. South America Prostate Biopsy System Sales, by Prostate K Units (2022-2027)
  • Table 317. Brazil Prostate Biopsy System Sales, by Type K Units (2022-2027)
  • Table 318. Brazil Prostate Biopsy System Sales, by Application K Units (2022-2027)
  • Table 319. Brazil Prostate Biopsy System Sales, by Prostate K Units (2022-2027)
  • Table 320. Argentina Prostate Biopsy System Sales, by Type K Units (2022-2027)
  • Table 321. Argentina Prostate Biopsy System Sales, by Application K Units (2022-2027)
  • Table 322. Argentina Prostate Biopsy System Sales, by Prostate K Units (2022-2027)
  • Table 323. Rest of South America Prostate Biopsy System Sales, by Type K Units (2022-2027)
  • Table 324. Rest of South America Prostate Biopsy System Sales, by Application K Units (2022-2027)
  • Table 325. Rest of South America Prostate Biopsy System Sales, by Prostate K Units (2022-2027)
  • Table 326. Asia Pacific Prostate Biopsy System Sales, by Country K Units (2022-2027)
  • Table 327. Asia Pacific Prostate Biopsy System Sales, by Type K Units (2022-2027)
  • Table 328. Asia Pacific Prostate Biopsy System Sales, by Application K Units (2022-2027)
  • Table 329. Asia Pacific Prostate Biopsy System Sales, by Prostate K Units (2022-2027)
  • Table 330. China Prostate Biopsy System Sales, by Type K Units (2022-2027)
  • Table 331. China Prostate Biopsy System Sales, by Application K Units (2022-2027)
  • Table 332. China Prostate Biopsy System Sales, by Prostate K Units (2022-2027)
  • Table 333. Japan Prostate Biopsy System Sales, by Type K Units (2022-2027)
  • Table 334. Japan Prostate Biopsy System Sales, by Application K Units (2022-2027)
  • Table 335. Japan Prostate Biopsy System Sales, by Prostate K Units (2022-2027)
  • Table 336. India Prostate Biopsy System Sales, by Type K Units (2022-2027)
  • Table 337. India Prostate Biopsy System Sales, by Application K Units (2022-2027)
  • Table 338. India Prostate Biopsy System Sales, by Prostate K Units (2022-2027)
  • Table 339. South Korea Prostate Biopsy System Sales, by Type K Units (2022-2027)
  • Table 340. South Korea Prostate Biopsy System Sales, by Application K Units (2022-2027)
  • Table 341. South Korea Prostate Biopsy System Sales, by Prostate K Units (2022-2027)
  • Table 342. Taiwan Prostate Biopsy System Sales, by Type K Units (2022-2027)
  • Table 343. Taiwan Prostate Biopsy System Sales, by Application K Units (2022-2027)
  • Table 344. Taiwan Prostate Biopsy System Sales, by Prostate K Units (2022-2027)
  • Table 345. Australia Prostate Biopsy System Sales, by Type K Units (2022-2027)
  • Table 346. Australia Prostate Biopsy System Sales, by Application K Units (2022-2027)
  • Table 347. Australia Prostate Biopsy System Sales, by Prostate K Units (2022-2027)
  • Table 348. Rest of Asia-Pacific Prostate Biopsy System Sales, by Type K Units (2022-2027)
  • Table 349. Rest of Asia-Pacific Prostate Biopsy System Sales, by Application K Units (2022-2027)
  • Table 350. Rest of Asia-Pacific Prostate Biopsy System Sales, by Prostate K Units (2022-2027)
  • Table 351. Europe Prostate Biopsy System Sales, by Country K Units (2022-2027)
  • Table 352. Europe Prostate Biopsy System Sales, by Type K Units (2022-2027)
  • Table 353. Europe Prostate Biopsy System Sales, by Application K Units (2022-2027)
  • Table 354. Europe Prostate Biopsy System Sales, by Prostate K Units (2022-2027)
  • Table 355. Germany Prostate Biopsy System Sales, by Type K Units (2022-2027)
  • Table 356. Germany Prostate Biopsy System Sales, by Application K Units (2022-2027)
  • Table 357. Germany Prostate Biopsy System Sales, by Prostate K Units (2022-2027)
  • Table 358. France Prostate Biopsy System Sales, by Type K Units (2022-2027)
  • Table 359. France Prostate Biopsy System Sales, by Application K Units (2022-2027)
  • Table 360. France Prostate Biopsy System Sales, by Prostate K Units (2022-2027)
  • Table 361. Italy Prostate Biopsy System Sales, by Type K Units (2022-2027)
  • Table 362. Italy Prostate Biopsy System Sales, by Application K Units (2022-2027)
  • Table 363. Italy Prostate Biopsy System Sales, by Prostate K Units (2022-2027)
  • Table 364. United Kingdom Prostate Biopsy System Sales, by Type K Units (2022-2027)
  • Table 365. United Kingdom Prostate Biopsy System Sales, by Application K Units (2022-2027)
  • Table 366. United Kingdom Prostate Biopsy System Sales, by Prostate K Units (2022-2027)
  • Table 367. Netherlands Prostate Biopsy System Sales, by Type K Units (2022-2027)
  • Table 368. Netherlands Prostate Biopsy System Sales, by Application K Units (2022-2027)
  • Table 369. Netherlands Prostate Biopsy System Sales, by Prostate K Units (2022-2027)
  • Table 370. Rest of Europe Prostate Biopsy System Sales, by Type K Units (2022-2027)
  • Table 371. Rest of Europe Prostate Biopsy System Sales, by Application K Units (2022-2027)
  • Table 372. Rest of Europe Prostate Biopsy System Sales, by Prostate K Units (2022-2027)
  • Table 373. MEA Prostate Biopsy System Sales, by Country K Units (2022-2027)
  • Table 374. MEA Prostate Biopsy System Sales, by Type K Units (2022-2027)
  • Table 375. MEA Prostate Biopsy System Sales, by Application K Units (2022-2027)
  • Table 376. MEA Prostate Biopsy System Sales, by Prostate K Units (2022-2027)
  • Table 377. Middle East Prostate Biopsy System Sales, by Type K Units (2022-2027)
  • Table 378. Middle East Prostate Biopsy System Sales, by Application K Units (2022-2027)
  • Table 379. Middle East Prostate Biopsy System Sales, by Prostate K Units (2022-2027)
  • Table 380. Africa Prostate Biopsy System Sales, by Type K Units (2022-2027)
  • Table 381. Africa Prostate Biopsy System Sales, by Application K Units (2022-2027)
  • Table 382. Africa Prostate Biopsy System Sales, by Prostate K Units (2022-2027)
  • Table 383. North America Prostate Biopsy System Sales, by Country K Units (2022-2027)
  • Table 384. North America Prostate Biopsy System Sales, by Type K Units (2022-2027)
  • Table 385. North America Prostate Biopsy System Sales, by Application K Units (2022-2027)
  • Table 386. North America Prostate Biopsy System Sales, by Prostate K Units (2022-2027)
  • Table 387. United States Prostate Biopsy System Sales, by Type K Units (2022-2027)
  • Table 388. United States Prostate Biopsy System Sales, by Application K Units (2022-2027)
  • Table 389. United States Prostate Biopsy System Sales, by Prostate K Units (2022-2027)
  • Table 390. Canada Prostate Biopsy System Sales, by Type K Units (2022-2027)
  • Table 391. Canada Prostate Biopsy System Sales, by Application K Units (2022-2027)
  • Table 392. Canada Prostate Biopsy System Sales, by Prostate K Units (2022-2027)
  • Table 393. Mexico Prostate Biopsy System Sales, by Type K Units (2022-2027)
  • Table 394. Mexico Prostate Biopsy System Sales, by Application K Units (2022-2027)
  • Table 395. Mexico Prostate Biopsy System Sales, by Prostate K Units (2022-2027)
  • Table 396. Prostate Biopsy System: by Type(USD/Units)
  • Table 397. Research Programs/Design for This Report
  • Table 398. Key Data Information from Secondary Sources
  • Table 399. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Prostate Biopsy System: by Type USD Million (2016-2021)
  • Figure 5. Global Prostate Biopsy System: by Application USD Million (2016-2021)
  • Figure 6. Global Prostate Biopsy System: by Prostate USD Million (2016-2021)
  • Figure 7. South America Prostate Biopsy System Share (%), by Country
  • Figure 8. Asia Pacific Prostate Biopsy System Share (%), by Country
  • Figure 9. Europe Prostate Biopsy System Share (%), by Country
  • Figure 10. MEA Prostate Biopsy System Share (%), by Country
  • Figure 11. North America Prostate Biopsy System Share (%), by Country
  • Figure 12. Global Prostate Biopsy System: by Type K Units (2016-2021)
  • Figure 13. Global Prostate Biopsy System: by Application K Units (2016-2021)
  • Figure 14. Global Prostate Biopsy System: by Prostate K Units (2016-2021)
  • Figure 15. South America Prostate Biopsy System Share (%), by Country
  • Figure 16. Asia Pacific Prostate Biopsy System Share (%), by Country
  • Figure 17. Europe Prostate Biopsy System Share (%), by Country
  • Figure 18. MEA Prostate Biopsy System Share (%), by Country
  • Figure 19. North America Prostate Biopsy System Share (%), by Country
  • Figure 20. Global Prostate Biopsy System: by Type USD/Units (2016-2021)
  • Figure 21. Global Prostate Biopsy System share by Players 2021 (%)
  • Figure 22. Global Prostate Biopsy System share by Players (Top 3) 2021(%)
  • Figure 23. Global Prostate Biopsy System share by Players (Top 5) 2021(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Bard (Georgia) Revenue, Net Income and Gross profit
  • Figure 26. Bard (Georgia) Revenue: by Geography 2021
  • Figure 27. Argon Medical Devices (United States) Revenue, Net Income and Gross profit
  • Figure 28. Argon Medical Devices (United States) Revenue: by Geography 2021
  • Figure 29. Philips (Netherlands) Revenue, Net Income and Gross profit
  • Figure 30. Philips (Netherlands) Revenue: by Geography 2021
  • Figure 31. Cook Group (United States) Revenue, Net Income and Gross profit
  • Figure 32. Cook Group (United States) Revenue: by Geography 2021
  • Figure 33. UROMED (United States) Revenue, Net Income and Gross profit
  • Figure 34. UROMED (United States) Revenue: by Geography 2021
  • Figure 35. Sterylab (Italy) Revenue, Net Income and Gross profit
  • Figure 36. Sterylab (Italy) Revenue: by Geography 2021
  • Figure 37. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 38. Boston Scientific Corporation (United States) Revenue: by Geography 2021
  • Figure 39. Geotekmedical (Turkey) Revenue, Net Income and Gross profit
  • Figure 40. Geotekmedical (Turkey) Revenue: by Geography 2021
  • Figure 41. Eigen (United States) Revenue, Net Income and Gross profit
  • Figure 42. Eigen (United States) Revenue: by Geography 2021
  • Figure 43. Samsung Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 44. Samsung Healthcare (United States) Revenue: by Geography 2021
  • Figure 45. Global Prostate Biopsy System: by Type USD Million (2022-2027)
  • Figure 46. Global Prostate Biopsy System: by Application USD Million (2022-2027)
  • Figure 47. Global Prostate Biopsy System: by Prostate USD Million (2022-2027)
  • Figure 48. South America Prostate Biopsy System Share (%), by Country
  • Figure 49. Asia Pacific Prostate Biopsy System Share (%), by Country
  • Figure 50. Europe Prostate Biopsy System Share (%), by Country
  • Figure 51. MEA Prostate Biopsy System Share (%), by Country
  • Figure 52. North America Prostate Biopsy System Share (%), by Country
  • Figure 53. Global Prostate Biopsy System: by Type K Units (2022-2027)
  • Figure 54. Global Prostate Biopsy System: by Application K Units (2022-2027)
  • Figure 55. Global Prostate Biopsy System: by Prostate K Units (2022-2027)
  • Figure 56. South America Prostate Biopsy System Share (%), by Country
  • Figure 57. Asia Pacific Prostate Biopsy System Share (%), by Country
  • Figure 58. Europe Prostate Biopsy System Share (%), by Country
  • Figure 59. MEA Prostate Biopsy System Share (%), by Country
  • Figure 60. North America Prostate Biopsy System Share (%), by Country
  • Figure 61. Global Prostate Biopsy System: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Bard (Georgia)
  • Argon Medical Devices (United States)
  • Philips (Netherlands)
  • Cook Group (United States)
  • UROMED (United States)
  • Sterylab (Italy)
  • Boston Scientific Corporation (United States)
  • Geotekmedical (Turkey)
  • Eigen (United States)
  • Samsung Healthcare (United States)
Additional players considered in the study are as follows:
Biobot Surgical Pte Ltd (Singapore) , Amecath (Egypt)
Select User Access Type

Key Highlights of Report


Jan 2022 240 Pages 74 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global and China Prostate Biopsy System Quantitative research analysis
Global and China Prostate Biopsy System Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2017-2021; Base year: 2021; Forecast period: 2021 to 2027
Companies that are profiled in Global Prostate Biopsy System Market are Bard (Georgia), Argon Medical Devices (United States), Philips (Netherlands), Cook Group (United States), UROMED (United States), Sterylab (Italy), Boston Scientific Corporation (United States), Geotekmedical (Turkey), Eigen (United States) and Samsung Healthcare (United States) etc.
The prostate Biopsy system is designed to provide high quality and reliable core samples. It is the system provides consistent, excellent core samples. With the help of a prostate biopsy needle which collects the number of tissue samples from the prostate gland. This procedure is performed by skilled professionals who specialize in the urinary system and men's sex organs. It makes easy access to the tissue sample. This system helps in achieving high detection rates increase in diagnostic certainty in the case of carcinoma.

Know More About Global and China Prostate Biopsy System Report?

Have a Query? Click Here

Other Related Reports

Ophthalmic Imaging Equipment Comprehensive Study by Type (Vision Care Products {Spectacles, and Contact Lenses}, Ophthalmology Surgical Devices{Cataract Surgical Devices,, Vitreoretinal Surgical Devi...
$ 3750
Urological Examination Chairs Comprehensive Study by Operability (Electric, Mechanical, Hydraulic, Electropneumatic), Sections (2-Section, 3-Section, 4-Section), End Use (Hospital, Specialty Clinic, ...
$ 3350
Toe Separators Comprehensive Study by Type (Gel Toe Separators, Foam Toe Separators), Application (Adult Toe Separators, Children Toe Separators), Sales Channel (Hypermarket, Supermarket, E-commerce,...
$ 3500
Durable Medical Equipment Comprehensive Study by Type (Personal Mobility Devices {Wheelchairs, Crutches & Canes, Walkers, and Others}, Medical Furniture {Medical Beds, Mattress, Stretchers, Lift Chai...
$ 3750
Medical Binocular Loupe Comprehensive Study by Application (Hospitals, Dental Clinics, Ambulatory Surgical Centers, Others), Product Type (TTL Loupes, Flip-up Loupes), Distribution Channel (E-Platfor...
$ 3650
Tension Hand Grip Comprehensive Study by Type (Non-adjustable Tension Hand Grip, Adjustable Tension Hand Grip), Application (Gyms, Sports, Personal, Others), Distribution Channel (Online Channel, Off...
$ 3450